Atenolol

CHEMBL24 Phase 4 Onaylandı Small molecule
Half-Life
6-7 hours
Bioavailability
Protein Binding
Molecular Weight
266.3 g/mol
LogP
0.2
Phase
4

A beta-1 selective adrenergic blocker that slows the heart rate and reduces the force of heart contractions, lowering blood pressure and decreasing the heart's oxygen demand. It is used for hypertension, angina, and heart rhythm disorders including atrial fibrillation.

Moleküler Ağırlık

266,3360 g/mol

LogP

0,20

TPSA

84,60 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

İlaç Sınıfları

Etki Mekanizması

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

Pharmacokinetics (PK)

Half-Life 6-7 hours

Pharmacodynamics (PD)

Mekanizma

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCC(O)COc1ccc(CC(N)=O)cc1

InChI

InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)

Molecular Formula

C14H22N2O3

HBD / HBA

3 / 4

Döndürülebilir Bağlar

8

Ağır Atomlar

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A beta-1 selective adrenergic blocker that slows the heart rate and reduces the force of heart contractions, lowering blood pressure and decreasing the heart's oxygen demand. It is used for hypertension, angina, and heart rhythm disorders including atrial fibrillation.

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

Key pharmacokinetic parameters for Atenolol: Half-life: 6-7 hours.

Yes, Atenolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL24. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2249. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.